<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092023000700534</article-id>
<article-id pub-id-type="doi">10.35366/114853</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Manejo de la hipertensión intracraneana con solución salina hipertónica al 7.5% versus 3% del paciente neurocrítico]]></article-title>
<article-title xml:lang="en"><![CDATA[Management of intracranial hypertension with 7.5% versus 3% saline solution for neurocritical patient]]></article-title>
<article-title xml:lang="pt"><![CDATA[Manejo da hipertensão intracraniana com solução salina hipertônica 7.5% versus 3% para paciente neurocrítico]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pimentel Arce]]></surname>
<given-names><![CDATA[Elsa Guadalupe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramírez Rangel]]></surname>
<given-names><![CDATA[Josué Jair]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gómez González]]></surname>
<given-names><![CDATA[María Natalia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jiménez Correa]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González Carrillo]]></surname>
<given-names><![CDATA[Pedro Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Centro Médico Nacional del Bajío No. 1 Unidad Médica de Alta Especialidad]]></institution>
<addr-line><![CDATA[León Guanajuato]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>37</volume>
<numero>7</numero>
<fpage>534</fpage>
<lpage>541</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092023000700534&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092023000700534&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092023000700534&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  la lesión cerebral aguda es un padecimiento potencialmente mortal, que puede asociarse a distintas disfunciones. Acorde a la BTF (Brain Trauma Foundation por sus siglas en inglés) se considera hipertensión intracraneal (HIC) todo valor &gt; 22 mmHg. El control de la presión intracraneal (PIC) es la piedra angular del paciente neurocrítico; un adecuado tratamiento reduce la lesión secundaria, por ello el mantener un monitoreo estrecho. El Doppler transcraneal (DTC) tiene la característica de ser continuo y dinámico, otorga la medición del índice de pulsatilidad (IP) que se correlaciona con aumento de PIC. Dentro de las medidas antiedema en un paciente con HIC se ha evaluado el efecto de solución salina a diferentes concentraciones, sin referir una superioridad, por lo cual el presente protocolo evalúa el efecto significativo en la velocidad y el índice de pulsatilidad de la arteria cerebral media (ACM) y la medición de la vaina del nervio óptico (VNO) en los pacientes que reciben solución salina hipertónica (HTS) al 7.5% versus 3% para el manejo de la HIC.  Material y métodos:  estudio de cohorte, comparativo, prospectivo, analítico; fueron incluidos 42 pacientes, ambos géneros, mayores de 18 años con datos de HIC; eliminados los que fallecieron posterior a la administración de solución hiperosmolar, pacientes con mala ventana sonográfica para toma de mediciones de DTC, y sujetos a quienes no se les administró la solución hiperosmolar en tiempo y forma. Muestreo no probabilístico por disponibilidad de casos, aleatorizado para recibir HTS al 3% o al 7.5% como tratamiento para la HIC, calculada a 2 mL/kg de peso, administrada para 20 minutos, vía intravenosa y con un lapso de 30 minutos para toma de nueva medición. El objetivo primario fue determinar el efecto de la terapia con solución hipertónica al 3% versus 7.5% como tratamiento para HIC, valorando con velocidades de la ACM y VNO.  Resultados:  se incluyeron 42 pacientes, ambos géneros con edad media de 44.57 ± 14.3 años; en la relación del grupo con HTS 7.5%, demostró mayor eficacia con una p de 0.028 y en la comparativa de las velocidades ACM se obtuvo mayor varianza en el grupo HTS al 7.5% con una p de 0.04; ambos grupos tuvieron un cambio global de la PIC con una p de 0.062. La presión de perfusión cerebral (PPC) tuvo mayor cambio en el grupo de HTS 7.5% con AUC de 0.89, p de 0.07 y una diferencia entre áreas de 0.0009.  Conclusiones:  la solución salina hipertónica al 7.5%, presentó mayor relevancia en el tratamiento para pacientes neurocríticos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  acute brain injury is a critical, life-threatening condition that can be associated to multiple failures. According to the brain trauma foundation, intracranial hypertension is defined as a value of equal or more than 22 mmHg. Control of intracranial pressure is the key to every neurocritical patient. A proper treatment reduces the secondary insult and the mortality that comes with it. Therefore, it is vital to achieve a to achieve a close follow up to every neurocritical patient. Transcranial doppler is a continuous and dynamic and it provides the measurement of the pulsatility index, which correlates with increased intracranial pressure. Within the anti-edema treatment, the effect of saline solution at different concentrations has been evaluated, without referring to a superiority, which is why this protocol evaluates the significant effect on the velocity and pulsatility index of the cerebral artery (MCA) and optic nerve sheath (ONS) measurement in patients receiving 7.5% versus 3% hypertonic saline (HTS) for the management of ICH.  Material and methods:  cohort, comparative, prospective and analytical, trial was performed, with a sample of 42 patients, both genders, over 18 years with ICH data, eliminating those who failed subsequent administration of hyperosmolar solution, poor sonographic window for taking TCD measurements, who were not administered the hyperosmolar solution in a timely manner. Non-probabilistic sampling due to availability of cases, randomized to receive 3% or 7.5% HTS as a treatment for ICH, calculated at 2 mL/kg of weight, administered for 20 minutes, intravenously and with a 30-minute period for taking new measurement. The primary objective was to determine the effect of therapy with 3% versus 7.5% hypertonic solution as a treatment for ICH by assessing MCA and VNO velocities.  Results:  we included 42 patients both genders with a mean age of 44.57 ± 14.3 years, in the relationship of the group with HTS 7.5% demonstrated greater efficacy with a p of 0.028 and in the comparison of MCA velocities, greater variance was obtained in the HTS group at 7.5% with a p of 0.04, both groups had a global change in ICP with a p of 0.062. Cerebral perfusion pressure (CPP) had a greater change in the HTS 7.5% group with an AUC of 0.89, p of 0.07 and a difference between areas of 0.0009.  Conclusion:  the 7.5% hypertonic saline solution presented greater relevance in the treatment of neurocritical patients.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  a lesão cerebral aguda é uma condição potencialmente fatal que pode estar associada a diversas disfunções. Segundo a BTF (Brain Trauma Foundation por suas siglas em inglês), qualquer valor &gt; 22 mmHg é considerado hipertensão intracraniana (HIC). O controle da pressão intracraniana (PIC) é a pedra angular do paciente neurocrítico; o tratamento adequado reduz a lesão secundária, mantendo assim um monitoramento rigoroso. O Doppler transcraniano (DTC) tem a característica de ser contínuo e dinâmico, proporciona a medida do índice de pulsatilidade (IP) que se correlaciona com o aumento da PIC. Dentro das medidas antiedema em paciente com HIC, avaliou-se o efeito da solução salina em diferentes concentrações, sem relatar superioridade, por isso este protocolo avalia o efeito significativo na velocidade e no índice de pulsatilidade da artéria cerebral (ACM) e medição da bainha do nervo óptico (BNO) em pacientes que receberam solução salina hipertônica (SSH) 7.5% versus 3% para o tratamento de HIC.  Material e métodos:  estudo de coorte comparativo, prospectivo e analítico, envolvendo 42 pacientes, ambos os sexos, maiores de 18 anos com dados de HIC, eliminando aqueles que morreram após administração de solução hiperosmolar, janela ultrassonografia inadequada para fazer medições de DTC, que não foram administrados a solução hiperosmolar em tempo hábil. Amostra não probabilística por disponibilidade de casos, randomizados para receber SSH 3% ou 7.5% como tratamento para HIC, calculado em 2 mL/kg de peso, administrado por 20 minutos, por via intravenosa e com período de 30 minutos para nova medição. O objetivo principal foi determinar o efeito da terapia com solução hipertônica a 3% versus 7.5% como tratamento para HIC, avaliando as velocidades de MCA e BNO.  Resultados:  incluíram-se 42 pacientes, ambos os sexos com média de idade de 44.57 ± 14.3 anos, na relação do grupo com SSH 7.5% demonstraram maior eficácia com p de 0.028 e na comparação das velocidades da ACM obteve-se maior variância no grupo SSH em 7.5% com p de 0.04, ambos os grupos tiveram alteração global na PIC com p de 0.062. A pressão de perfusão cerebral (PPC) teve maior alteração no grupo SSH 7.5% com AUC de 0.89, p de 0.07 e diferença entre áreas de 0.0009.  Conclusões:  a solução salina hipertônica 7.5% apresentou maior relevância no tratamento de pacientes neurocríticos.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[solución hipertónica]]></kwd>
<kwd lng="es"><![CDATA[hipertensión intracraneana]]></kwd>
<kwd lng="es"><![CDATA[flujo de arteria cerebral media]]></kwd>
<kwd lng="es"><![CDATA[vaina del nervio óptico]]></kwd>
<kwd lng="en"><![CDATA[hypertonic solution]]></kwd>
<kwd lng="en"><![CDATA[intracranial hypertension]]></kwd>
<kwd lng="en"><![CDATA[middle cerebral artery flow]]></kwd>
<kwd lng="en"><![CDATA[optic nerve sheath]]></kwd>
<kwd lng="pt"><![CDATA[solução hipertônica]]></kwd>
<kwd lng="pt"><![CDATA[hipertensão intracraniana]]></kwd>
<kwd lng="pt"><![CDATA[fluxo da artéria cerebral média]]></kwd>
<kwd lng="pt"><![CDATA[bainha do nervo óptico]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hickey]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chapter 174: Intracranial hypertension]]></article-title>
<source><![CDATA[Atlee JLBT-C in A]]></source>
<year>2007</year>
<page-range>701-3</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[W.B. Saunders]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schizodimos]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Soulountsi]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Iasonidou]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kapravelos]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An overview of management of intracranial hypertension in the intensive care unit]]></article-title>
<source><![CDATA[J Anesth]]></source>
<year>2020</year>
<volume>34</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>741-57</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Robba]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Citerio]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How I manage intracranial hypertension]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2019</year>
<volume>23</volume>
<page-range>243</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Changa]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Czeisler]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Lord]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of elevated intracranial pressure: a review]]></article-title>
<source><![CDATA[Curr Neurol Neurosci Rep]]></source>
<year>2019</year>
<volume>19</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>99</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Raboel]]></surname>
<given-names><![CDATA[PH]]></given-names>
</name>
<name>
<surname><![CDATA[Bartek]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Andresen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bellander]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Romner]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intracranial pressure monitoring: invasive versus non-invasive methods-a review]]></article-title>
<source><![CDATA[Crit Care Res Pract]]></source>
<year>2012</year>
<volume>2012</volume>
<page-range>950393</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Canac]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Jalaleddini]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Thorpe]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
<name>
<surname><![CDATA[Thibeault]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Hamilton]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Review: pathophysiology of intracranial hypertension and noninvasive intracranial pressure monitoring]]></article-title>
<source><![CDATA[Fluids Barriers CNS]]></source>
<year>2020</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>40</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bellner]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Romner]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Reinstrup]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Kristiansson]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Ryding]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Brandt]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transcranial Doppler sonography pulsatility index (PI) reflects intracranial pressure (ICP)]]></article-title>
<source><![CDATA[Surg Neurol]]></source>
<year>2004</year>
<volume>62</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>45-51</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arjona Villanueva]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Borrego Domínguez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Huidobro]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bárbara Fernández]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Verdú]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Hipertensión intracraneal. Protocolos diagnóstico terapéuticos de la AEP: neurología pediátrica]]></source>
<year>2008</year>
<edition>2ª</edition>
<page-range>244-54</page-range><publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[AEP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hashmi]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intracranial hypertension]]></article-title>
<source><![CDATA[StatPearls]]></source>
<year>2023</year>
<publisher-loc><![CDATA[Treasure Island (FL) ]]></publisher-loc>
<publisher-name><![CDATA[StatPearls Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cook]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Morgan Jones]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Hawryluk]]></surname>
<given-names><![CDATA[GWJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mailloux]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[McLaughlin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Papangelou]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guidelines for the acute treatment of cerebral edema in neurocritical care patients]]></article-title>
<source><![CDATA[Neurocrit Care]]></source>
<year>2020</year>
<volume>32</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>647-66</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heldt]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Zoerle]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Teichmann]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Stocchetti]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intracranial pressure and intracranial elastance monitoring in neurocritical care]]></article-title>
<source><![CDATA[Annu Rev Biomed Eng]]></source>
<year>2019</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>523-49</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gilo Arrojo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera Muñoz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Anciones]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hipertensión intracraneal aguda]]></article-title>
<source><![CDATA[Neurologia]]></source>
<year>2010</year>
<volume>25</volume>
<page-range>3-10</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kirmani]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Yahia]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Qureshi]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
<name>
<surname><![CDATA[Hopkins]]></surname>
<given-names><![CDATA[LN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intracranial hypertension]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Aminoff]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Daroff RBBT-E of the NS]]></source>
<year>2014</year>
<edition>2nd</edition>
<page-range>742-3</page-range><publisher-loc><![CDATA[Oxford ]]></publisher-loc>
<publisher-name><![CDATA[Academic Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Friedman]]></surname>
<given-names><![CDATA[DI]]></given-names>
</name>
<name>
<surname><![CDATA[Jacobson]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic criteria for idiopathic intracranial hypertension]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2002</year>
<volume>59</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1492-5</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alexandrov]]></surname>
<given-names><![CDATA[AV]]></given-names>
</name>
<name>
<surname><![CDATA[Sloan]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[LK]]></given-names>
</name>
<name>
<surname><![CDATA[Douville]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Razumovsky]]></surname>
<given-names><![CDATA[AY]]></given-names>
</name>
<name>
<surname><![CDATA[Koroshetz]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Practice standards for transcranial Doppler ultrasound: part I--test performance]]></article-title>
<source><![CDATA[J Neuroimaging]]></source>
<year>2007</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>11-8</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz-Carrillo]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aplicaciones ultrasonográficas en neuromonitoreo: Doppler transcraneal]]></article-title>
<source><![CDATA[Rev Mex Anestesiol]]></source>
<year>2017</year>
<volume>40</volume>
<numero>S1</numero>
<issue>S1</issue>
<page-range>258-69</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rangel-Castillo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gopinath]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Robertson]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of intracranial hypertension]]></article-title>
<source><![CDATA[Neurol Clin]]></source>
<year>2008</year>
<volume>26</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>521-41</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Battison]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Andrews]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Graham]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Petty]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury]]></article-title>
<source><![CDATA[Crit Care Med]]></source>
<year>2005</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>196-202</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ye]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hypertonic saline and mannitol in patients with traumatic brain injury: A systematic and meta-analysis]]></article-title>
<source><![CDATA[Medicine (Baltimore)]]></source>
<year>2020</year>
<volume>99</volume>
<numero>35</numero>
<issue>35</issue>
<page-range>e21655</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[YY]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[YC]]></given-names>
</name>
<name>
<surname><![CDATA[Tu]]></surname>
<given-names><![CDATA[YK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy and safety of hypertonic saline solutions in the treatment of severe head injury]]></article-title>
<source><![CDATA[Surg Neurol]]></source>
<year>2006</year>
<volume>65</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>539-discussion 546</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
